The Medical Letter on Drugs and Therapeutics
ONLINE
ONLY
ARTICLE
ONLY
ARTICLE
November 24, 2025
Comparison Chart: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors (online only)
Download PDF: US English
Med Lett Drugs Ther. 2025 Nov 24;67(1742):e191-4 doi:10.58347/tml.2025.1742b
Disclosures
Principal Faculty- Mark Abramowicz, M.D., President has disclosed no relevant financial relationships.
- Jean-Marie Pflomm, Pharm.D., Editor in Chief has disclosed no relevant financial relationships.
- Brinda M. Shah, Pharm.D., Consulting Editor has disclosed no relevant financial relationships.
Objective(s)
Upon completion of this activity, the participant will be able to:
- Explain the current approach to the management of type 2 diabetes.
- Discuss the pharmacological options available for treatment of type 2 diabetes and compare them based on their efficacy, dosage and administration, drug interactions, and potential adverse effects.
- Determine the most appropriate therapy given the clinical presentation of an individual patient with type 2 diabetes.
View the Comparison Chart: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
Download PDF: US English
© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and
complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any
damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
Previous article